Heart Test Laboratories (NASDAQ:HSCS) Shares Down 0.7% – Time to Sell?

Heart Test Laboratories, Inc. (NASDAQ:HSCS) shares traded down 0.7% on Friday . The stock traded as low as $3.20 and last traded at $3.48. 8,447 shares changed hands during trading, a decline of 93% from the average session volume of 127,402 shares. The stock had previously closed at $3.50.

Analysts Set New Price Targets

HSCS has been the subject of a number of analyst reports. Ascendiant Capital Markets cut their price objective on shares of Heart Test Laboratories from $15.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, March 18th. Maxim Group reissued a “buy” rating and issued a $12.00 price target on shares of Heart Test Laboratories in a report on Wednesday, December 18th.

Heart Test Laboratories Price Performance

The business has a 50 day simple moving average of $3.26 and a two-hundred day simple moving average of $3.40. The firm has a market capitalization of $3.76 million, a P/E ratio of -0.44 and a beta of 2.71. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.52 and a current ratio of 1.72.

Heart Test Laboratories (NASDAQ:HSCS) last posted its quarterly earnings data on Thursday, March 13th. The company reported ($2.57) earnings per share for the quarter, missing the consensus estimate of ($2.53) by ($0.04). On average, sell-side analysts expect that Heart Test Laboratories, Inc. will post -10.01 EPS for the current fiscal year.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.